89 results
8-K
EX-99.1
NAOV
NanoVibronix Inc
28 Mar 24
NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield
9:09am
to PainShield and UroShield.
Brian Murphy, Chief Executive Officer of NanoVibronix, Inc., said, “Teaming up with Veranex provides us with access
8-K
EX-99.1
ydbnt7w
7 Nov 23
Receives Stocking Order from U.K. Distribution Partner in Anticipation of Increasing Demand
8:30am
8-K
EX-99.1
i79ihjipbe9h4d ui
27 Sep 23
NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services’ Drug Tariff
8:00am
8-K
EX-10.1
sv3ofzv
1 Sep 23
NanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
4:30pm
8-K
EX-10.2
ejd 2rm00
1 Sep 23
NanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
4:30pm
8-K
EX-99.1
hxtnyscir 0a6
28 Aug 23
NanoVibronix Applies for Inclusion of UroShield Products in NHS Prescription Services’ Drug Tariff
8:30am
8-K
EX-10.1
a960aa0rbp jk
1 Dec 22
NanoVibronix Announces $2.4 Million Registered
6:06am
424B5
7g978k4 9fofipbn24
30 Nov 22
Prospectus supplement for primary offering
5:29pm